Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Cabodi

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Journal of Proteome Research|May 26, 2007
Quantitation of multisite EGF receptor phosphorylation using mass spectrometry and a novel normalization approachElisabetta Boeri Erba, Rune Matthiesen, Jakob Bunkenborg, et al.
European Journal of Cell Biology|October 22, 2010
p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1Giusy Tornillo, Brigitte Bisaro, Maria del Pilar Camacho-Leal, et al.
Journal of Cell Science|March 17, 2004
p130Cas interacts with estrogen receptor alpha and modulates non-genomic estrogen signaling in breast cancer cellsSara Cabodi, Laura Moro, Germano Baj, et al.
Scientific Reports|March 1, 2019
Modeling ErbB2-p130Cas interaction to design new potential anticancer agentsAndrea Costamagna, Matteo Rossi Sebastiano, Dora Natalini, et al.
Plos One|December 15, 2012
p130Cas over-expression impairs mammary branching morphogenesis in response to estrogen and EGFMaria del Pilar Camacho Leal, Alessandra Pincini, Giusy Tornillo, et al.
International Journal of Molecular Sciences|August 29, 2024
Pro-Osteogenic Effect of the Nutraceutical BlastiMin Complex<sup>®</sup> in Women with Osteoporosis or Osteopenia: An Open Intervention Clinical TrialSofia Sabatelli, Emanuele-Salvatore Scarpa, Angelica Giuliani, et al.
Scientific Reports|November 24, 2019
Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agentsAndrea Costamagna, Matteo Rossi Sebastiano, Dora Natalini, et al.
Molecular Biology of the Cell|December 6, 2003
P130Cas-associated protein (p140Cap) as a new tyrosine-phosphorylated protein involved in cell spreadingPaola Di Stefano, Sara Cabodi, Elisabetta Boeri Erba, et al.
Cell Cycle (Georgetown, Tex.)|February 28, 2015
Dbl oncogene expression in MCF-10 A epithelial cells disrupts mammary acinar architecture, induces EMT and angiogenic factor secretionCristina Vanni, Marzia Ognibene, Federica Finetti, et al.
American Journal of Cancer Research|October 14, 2011
The adaptor proteins p140CAP and p130CAS as molecular hubs in cell migration and invasion of cancer cellsPaola Di Stefano, Maria Pilar Camacho Leal, Giusy Tornillo, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Journal of Proteome Research|May 26, 2007
Quantitation of multisite EGF receptor phosphorylation using mass spectrometry and a novel normalization approachElisabetta Boeri Erba, Rune Matthiesen, Jakob Bunkenborg, et al.
European Journal of Cell Biology|October 22, 2010
p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1Giusy Tornillo, Brigitte Bisaro, Maria del Pilar Camacho-Leal, et al.
Journal of Cell Science|March 17, 2004
p130Cas interacts with estrogen receptor alpha and modulates non-genomic estrogen signaling in breast cancer cellsSara Cabodi, Laura Moro, Germano Baj, et al.
Scientific Reports|March 1, 2019
Modeling ErbB2-p130Cas interaction to design new potential anticancer agentsAndrea Costamagna, Matteo Rossi Sebastiano, Dora Natalini, et al.
Plos One|December 15, 2012
p130Cas over-expression impairs mammary branching morphogenesis in response to estrogen and EGFMaria del Pilar Camacho Leal, Alessandra Pincini, Giusy Tornillo, et al.
International Journal of Molecular Sciences|August 29, 2024
Pro-Osteogenic Effect of the Nutraceutical BlastiMin Complex<sup>®</sup> in Women with Osteoporosis or Osteopenia: An Open Intervention Clinical TrialSofia Sabatelli, Emanuele-Salvatore Scarpa, Angelica Giuliani, et al.
Scientific Reports|November 24, 2019
Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agentsAndrea Costamagna, Matteo Rossi Sebastiano, Dora Natalini, et al.
Molecular Biology of the Cell|December 6, 2003
P130Cas-associated protein (p140Cap) as a new tyrosine-phosphorylated protein involved in cell spreadingPaola Di Stefano, Sara Cabodi, Elisabetta Boeri Erba, et al.
Cell Cycle (Georgetown, Tex.)|February 28, 2015
Dbl oncogene expression in MCF-10 A epithelial cells disrupts mammary acinar architecture, induces EMT and angiogenic factor secretionCristina Vanni, Marzia Ognibene, Federica Finetti, et al.
American Journal of Cancer Research|October 14, 2011
The adaptor proteins p140CAP and p130CAS as molecular hubs in cell migration and invasion of cancer cellsPaola Di Stefano, Maria Pilar Camacho Leal, Giusy Tornillo, et al.
Pageof 5